The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fishelevich, R.
Right arrow Articles by Gaspari, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fishelevich, R.
Right arrow Articles by Gaspari, A. A.
The Journal of Immunology, 2006, 176: 2590-2599.
Copyright © 2006 by The American Association of Immunologists

Ceramide-Dependent Regulation of Human Epidermal Keratinocyte CD1d Expression during Terminal Differentiation1

Rita Fishelevich*, Alla Malanina*, Irina Luzina{dagger}, Sergei Atamas{dagger}, Miriam J. Smyth{ddagger}, Steven A. Porcelli§ and Anthony A. Gaspari2,*

* Department of Dermatology, {dagger} Division of Rheumatology, Department of Medicine, and {ddagger} Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201; § Department of Microbiology and Immunology and Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461; and Research Service, Veteran’s Administration Medical Center, Baltimore, MD 21201

Human keratinocytes (KC), when cultured under conditions to remain undifferentiated or to terminally differentiate, changed their cellular distribution of CD1d. As studied by confocal microscopy, undifferentiated KC had a pool of cytoplasmic CD1d, whereas after terminal differentiation, this molecule localized in the cell membrane, which recapitulates CD1d expression in vivo. A comparison of undifferentiated and differentiated cultured KC did not reveal any differences in the association with beta2-microglobulin, invariant chain of class II MHC, or patterns of glycosylation, suggesting that these biochemical properties are not regulating the cellular distribution of CD1d. Time-course studies of CD1d gene expression indicated that KC slowly increased gene expression with CaCl2-induced terminal differentiation. Increased CD1d gene expression was dependent on ceramide synthesis, because fumonisin B1, a ceramide synthetase inhibitor, blocked the increase in CD1d gene expression during terminal differentiation. Similarly, exogenous ceramide or the ceramidase inhibitor, B13, induced CD1d gene expression by undifferentiated, but not terminally differentiated, KC. A protein kinase C-{zeta} (PKC-{zeta}) inhibitor (a pseudosubstrate oligopeptide), but not a PKC-{alpha}beta inhibitor, significantly decreased CD1d gene expression by undifferentiated or ceramide-stimulated cultured, undifferentiated KC. As expected, downstream signaling events of PKC-{zeta} (JNK phosphorylation and NF-{kappa}B accumulation in the nucleus) were also attenuated. The calcineurin phosphatase inhibitor cyclosporine A, which blocks KC terminal differentiation, also blocked CD1d gene expression by cultured KC. In conclusion, this novel function of cellular ceramides extends the importance of this class of biologically active lipids beyond that of terminal differentiation and barrier function in normal human skin.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
L. E. N. Rees, L. Pazmany, D. Gutowska-Owsiak, C. F. Inman, A. Phillips, C. R. Stokes, N. Johnston, J. A. Koufman, G. Postma, M. Bailey, et al.
The Mucosal Immune Response to Laryngopharyngeal Reflux
Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1187 - 1193.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.